Found: 48
Select item for more details and to access through your institution.
Impact of gefitinib (‘Iressa’) treatment on the quality of life of patients with advanced non-small-cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2005, v. 131, n. 12, p. 783, doi. 10.1007/s00432-005-0029-9
- By:
- Publication type:
- Article
The impact of storage on extracellular vesicles: A systematic study.
- Published in:
- Journal of Extracellular Vesicles, 2022, v. 11, n. 2, p. 1, doi. 10.1002/jev2.12162
- By:
- Publication type:
- Article
Evaluation of Drug—Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 5, p. 424, doi. 10.3390/jpm11050424
- By:
- Publication type:
- Article
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01140-9
- By:
- Publication type:
- Article
Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohort.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01317-z
- By:
- Publication type:
- Article
Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 679, doi. 10.3390/vaccines10050679
- By:
- Publication type:
- Article
The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 203, doi. 10.3390/vaccines8020203
- By:
- Publication type:
- Article
Use of Adjuvant Chemotherapy After Surgery in Patients With Colon Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Rheumatic Diseases Development in Patients Treated by Anti-PD1 Immune Checkpoint Inhibitors: A Single-Centre Descriptive Study.
- Published in:
- Life (2075-1729), 2023, v. 13, n. 4, p. 877, doi. 10.3390/life13040877
- By:
- Publication type:
- Article
Docetaxel in advanced gastric cancer: review of the main clinical trials.
- Published in:
- 2003
- By:
- Publication type:
- Journal Article
Docetaxel in Advanced Gastric Cancer.
- Published in:
- Acta Oncologica, 2003, v. 42, n. 7, p. 693, doi. 10.1080/02841860310011014
- By:
- Publication type:
- Article
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with Sarcopenia.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3592, doi. 10.3390/cancers15143592
- By:
- Publication type:
- Article
Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients—A Retrospective Observational Study.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3422, doi. 10.3390/cancers15133422
- By:
- Publication type:
- Article
Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective Study.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6355, doi. 10.3390/cancers13246355
- By:
- Publication type:
- Article
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 2935, doi. 10.3390/cancers13122935
- By:
- Publication type:
- Article
Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2620, doi. 10.3390/cancers12092620
- By:
- Publication type:
- Article
Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 1, p. 42, doi. 10.3390/cancers11010042
- By:
- Publication type:
- Article
Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.657639
- By:
- Publication type:
- Article
Turbulent non-newtonian transport in a circular tube.
- Published in:
- AIChE Journal, 1976, v. 22, n. 6, p. 1142, doi. 10.1002/aic.690220627
- By:
- Publication type:
- Article
Gemcitabine-based Combinations for Inoperable Pancreatic Cancer: Have We Made Real Progress?
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 3, p. 525, doi. 10.1002/cncr.22809
- By:
- Publication type:
- Article
Sequential chemotherapy in nonsmall‐cell lung cancer: Cisplatin and gemcitabine followed by docetaxel.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 4, p. 727, doi. 10.1002/cncr.22480
- By:
- Publication type:
- Article
Fixed dose‐rate gemcitabine infusion as first‐line treatment for advanced‐stage carcinoma of the pancreas and biliary tree.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 6, p. 1237, doi. 10.1002/cncr.21286
- By:
- Publication type:
- Article
Pilot study of celecoxib and infusional 5‐fluorouracil as second‐line treatment for advanced pancreatic carcinoma.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 1, p. 133
- By:
- Publication type:
- Article
CD137<sup>+</sup> and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05142-6
- By:
- Publication type:
- Article
Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 3, p. 483, doi. 10.1111/1759-7714.14256
- By:
- Publication type:
- Article
Smoking status during first‐line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 6, p. 880, doi. 10.1111/1759-7714.13852
- By:
- Publication type:
- Article
Efficacy and Tolerability of Selective Internal Radiotherapy With Yttrium-90 as Consolidation Treatment After Chemotherapy in Metastatic Colorectal Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The role of opioids in cancer response to immunotherapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Encephalopathy as a prognostic factor in adults with acute disseminated encephalomyelitis following COVID-19.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 5, p. 2293, doi. 10.1007/s00415-021-10947-2
- By:
- Publication type:
- Article
Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19?
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis?
- Published in:
- Journal of Neurology, 2021, v. 268, n. 2, p. 717, doi. 10.1007/s00415-020-10322-7
- By:
- Publication type:
- Article
Corpus callosum infarction: radiological and histological findings.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Neuromyelitis optica and myotonic dystrophy type 2: a rare association with diagnostic implications.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Diagnosing autoimmune encephalitis in a real-world single-centre setting.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 2, p. 449, doi. 10.1007/s00415-019-09607-3
- By:
- Publication type:
- Article
High-dose steroid therapy for CNS inflammatory diseases increases INR in patients taking oral vitamin K antagonist.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 717, doi. 10.1007/s00280-007-0650-1
- By:
- Publication type:
- Article
Coexistence of three EGFR mutations in an NSCLC patient: A brief report.
- Published in:
- International Journal of Biological Markers, 2018, v. 33, n. 4, p. 545, doi. 10.1177/1724600818782200
- By:
- Publication type:
- Article
Comparison of Two Blood-Based Genotyping Tests to Investigate the KRAS G12C Mutation in Patients with Non-Small-Cell Lung Cancer at Failure of First-Line Treatments.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 12, p. 2196, doi. 10.3390/diagnostics11122196
- By:
- Publication type:
- Article
Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab.
- Published in:
- Oncology, 2017, v. 93, n. 1, p. 62, doi. 10.1159/000464328
- By:
- Publication type:
- Article
Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract Cancers.
- Published in:
- Oncology, 2009, v. 76, n. 4, p. 254, doi. 10.1159/000205388
- By:
- Publication type:
- Article
Fixed-Dose-Rate Gemcitabine: A Viable First-Line Treatment Option for Advanced Pancreatic and Biliary Tract Cancer.
- Published in:
- Oncologist, 2010, v. 15, n. 2, p. 1E, doi. 10.1634/theoncologist.2008-0135
- By:
- Publication type:
- Article
Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 3752, doi. 10.3390/ijms25073752
- By:
- Publication type:
- Article
Thyroid disorders in programmed death 1 inhibitor‐treated patients: Is previous therapy with tyrosine kinase inhibitors a predisposing factor?
- Published in:
- Clinical Endocrinology, 2020, v. 92, n. 3, p. 258, doi. 10.1111/cen.14135
- By:
- Publication type:
- Article
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice.
- Published in:
- 2019
- By:
- Publication type:
- journal article